Antineoplastic agents

Cell Line Origin Human Caucasian rectum adenocarcinoma Cell Line Description Established from a Grade IV adenocarcinoma of the rectum of a 53 year old Caucasian male. The cells produce CEA and electron microscopy reveals brush borders.

A cell-permeable imidazopyrimidine compound that acts a potent, ATP-competitive, reversible, and highly selective inhibitor of Syk tyrosine kinase activity (IC 50 = 10 nM) with no inhibitory effect against Btk, Fyn, Itk, Lyn, and Src even at

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

Cell Line Origin Human bladder carcinoma Cell Line Description Derivative of the original T24 human bladder carcinoma cell line. Tumours are not produced in nude mice but tumour formation has been noted in hamster cheek pouches.

Cell Line Origin Human colon carcinoma Cell Line Description Derived from a lung metastasis of colon carcinoma in a 72 year old male. Tumour tissue was inoculated sub-cutaneously and serially transplanted in BALB/c nude mice and subsequently

Cell Line Origin Human Caucasian glioblastoma Cell Line Description Derived from glioblastoma multiform tumour from a 61-year-old Caucasian male. Indefinite lifespan and anchorage independent but can enter viable G1 arrested state when deprived of

A cell-permeable, bioactive, non-toxic quinoline based compound that acts as a highly potent, ATP-non-competitive, tight-binding type II TAM (Tyro3, Axl, and Mer) kinase inhibitor (IC 50 = 8, 29, and 5 nM, respectively for Tyro3, Axl, and Mer).

Application Refer to the product&#8242s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

A potent synthetic anti-estrogen. A cell-permeable and reversible inhibitor of protein kinase C (IC 50 = 10 &#181M).

Protein Kinase C inhibitor. Tamoxifen Citrate Salt is a nonsteroidal triphenylethylene derivative.